Journal of Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.3 | Q1 | 88.9% | 1.683 | Q1 | 93.5% |
| 2024 | 5.5 | Q1 | 91.3% | 1.708 | Q1 | 93.8% |
| 2023 | 4.5 | Q1 | 84.5% | 1.366 | Q1 | 91.5% |
| 2022 | 4.1 | Q2 | 70.3% | 1.120 | Q1 | 88.6% |
| 2021 | 4.6 | Q2 | 72.1% | 1.014 | Q1 | 86.8% |
| 2020 | — | — | 1.333 | Q1 | 90.8% | |
| 2019 | — | — | 1.342 | Q1 | 91.0% | |
| 2018 | — | — | 1.672 | Q1 | 93.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0269-8811
ISSN
1461-7285
country
GBcoverage
1987-2026